Hyderabad-based pharma player Laurus Labs has received a licence from the Defence Research & Development Organisation (DRDO) for manufacturing and marketing Covid-19 drug 2-Deoxy-D-Glucose (2-DG) in India. The licence to Laurus Labs has been granted by DRDO as part of efforts to make the drug affordable and accessible to patients.
DRDO had recently invited expression of interest (EoI) from other pharma companies for manufacturing this drug and had said it would grant licences to 15 companies on a first-come, first-served basis. Meanwhile, the Council of Scientific & Industrial Research institution Indian Institute of Chemical Technology (CSIR-IICT) has been licencing the know-how for 2-DG synthesis to other companies, including Lee Pharma, Suven Pharma, Anthem Biosciences and Nosch Labs.
India's Gurindervir Singh became the fastest ever Indian sprinter as he clocked an incredible 10.09…
As the hype around the 2026 FIFA World Cup is growing day by day and…
Countdown for the most exciting sports tournament in the world has officially begun. Fans across…
Former India and Tamil Nadu all rounder Vijay Shankar has announced his retirement from domestic…
The Reserve Bank of India (RBI) has announced the record ₹2.87 lakh crore surplus transfer…
Indian central government is preparing to launch the major national initiative called the High-Powered Demography…